OVARIAN EPITHELIAL CANCER STAGE III

This adverse event was reported 16 times

OVARIAN EPITHELIAL CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VORINOSTAT 2 0.0009
1 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 2 0.0001
2 THALIDOMIDE 2 0.0001
3 LEFLUNOMIDE 5 0.0000
4 CONJUGATED ESTROGENS 2 0.0000
5 ESTROGENS, CONJUGATED 2 0.0000
6 ERGOCALCIFEROL 1 0.0000
7 PAROXETINE HYDROCHLORIDE 1 0.0000
8 CYCLOPHOSPHAMIDE FOR INJECTION 4 0.0000
9 CYCLOPHOSPHAMIDE 4 0.0000
See all drugs enriched for association with OVARIAN EPITHELIAL CANCER STAGE III